海利生物
(603718)
| 流通市值：25.31亿 | | | 总市值：25.42亿 |
| 流通股本：6.49亿 | | | 总股本：6.52亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 127,276,160.56 | 214,308,870.34 | 309,982,581.63 | 353,232,083.01 |
| 交易性金融资产 | 260,445,590.64 | 210,835,313.19 | 160,284,310.31 | 162,588,615.35 |
| 应收票据及应收账款 | 118,071,047.29 | 101,538,522.83 | 110,195,662.82 | 105,463,747.81 |
| 其中：应收票据 | 379,572.05 | 691,710 | 2,390,863.52 | 2,047,095 |
| 应收账款 | 117,691,475.24 | 100,846,812.83 | 107,804,799.3 | 103,416,652.81 |
| 应收款项融资 | - | 443,843.03 | - | - |
| 预付款项 | 8,087,686.49 | 3,914,228.55 | 4,127,443.61 | 3,710,075.19 |
| 其他应收款合计 | 4,186,185.47 | 3,139,648.08 | 5,509,526.44 | 2,812,954.06 |
| 存货 | 70,433,014.72 | 59,458,470.67 | 61,287,392.31 | 61,751,342.84 |
| 其他流动资产 | 2,048,867.1 | 2,204,618.43 | 2,403,614.28 | 1,379,700.36 |
| 流动资产合计 | 590,548,552.27 | 595,843,515.12 | 653,790,531.4 | 690,938,518.62 |
| 非流动资产: | | | | |
| 固定资产 | 103,093,487.68 | 38,805,531.47 | 38,573,319.65 | 39,502,967 |
| 在建工程 | 2,999,609.03 | - | 5,827,904.78 | 2,661,729.7 |
| 使用权资产 | 14,111,687.32 | 14,082,488.36 | 15,018,066.95 | 16,209,193.38 |
| 无形资产 | 48,929,189.69 | 50,703,325.22 | 53,377,285.37 | 54,234,958.4 |
| 商誉 | 442,664,815.4 | 381,822,654.75 | 1,020,272,123.92 | 1,019,645,700.98 |
| 长期待摊费用 | 22,425,813.96 | 22,230,408.81 | 16,248,992.25 | 16,850,876.22 |
| 递延所得税资产 | 108,673.72 | 6,967.86 | 115,205.25 | 732,845.71 |
| 其他非流动资产 | 24,029,820 | 21,614,710 | - | 2,539,000 |
| 非流动资产合计 | 658,363,096.8 | 529,266,086.47 | 1,149,432,898.17 | 1,152,377,271.39 |
| 资产总计 | 1,248,911,649.07 | 1,125,109,601.59 | 1,803,223,429.57 | 1,843,315,790.01 |
| 流动负债: | | | | |
| 短期借款 | 21,000,000 | 3,002,166.67 | 3,000,000 | - |
| 应付票据及应付账款 | 16,037,328.83 | 8,328,915.24 | 8,838,838.1 | 10,776,717.14 |
| 应付账款 | 16,037,328.83 | 8,328,915.24 | 8,838,838.1 | 10,776,717.14 |
| 合同负债 | 10,024,483.83 | 7,862,837.07 | 10,251,730.66 | 7,152,182.87 |
| 应付职工薪酬 | 8,229,705.69 | 7,130,137.4 | 10,605,192.29 | 14,083,197.7 |
| 应交税费 | 5,396,184.5 | 11,252,981.04 | 6,377,292.27 | 6,674,905.36 |
| 其他应付款合计 | 73,423,181.72 | 68,770,807.14 | 42,555,165.11 | 38,353,699.75 |
| 一年内到期的非流动负债 | 2,735,888.41 | 3,184,350.64 | 3,983,431.33 | 3,039,862.41 |
| 其他流动负债 | 1,580,946.56 | 2,010,341.52 | 44,644.59 | 41,492.85 |
| 流动负债合计 | 138,427,719.54 | 111,542,536.72 | 85,656,294.35 | 80,122,058.08 |
| 非流动负债: | | | | |
| 长期借款 | 56,287,500 | - | - | - |
| 租赁负债 | 10,924,414.98 | 10,396,974.14 | 11,202,026.34 | 12,583,091.83 |
| 递延所得税负债 | 107,255,451.05 | 107,203,823.73 | 9,100,348.49 | 8,893,468.12 |
| 非流动负债合计 | 174,467,366.03 | 117,600,797.87 | 20,302,374.83 | 21,476,559.95 |
| 负债合计 | 312,895,085.57 | 229,143,334.59 | 105,958,669.18 | 101,598,618.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 651,904,700 | 655,662,200 | 655,662,200 | 655,662,200 |
| 资本公积 | 204,625,270.11 | 229,317,046.69 | 277,874,621.44 | 276,383,135.19 |
| 减:库存股 | 13,208,549.36 | 31,226,654.25 | 31,750,562.25 | 31,750,562.25 |
| 盈余公积 | - | - | 108,213,650.13 | 108,213,650.13 |
| 未分配利润 | 43,019,093.07 | 28,288,352.15 | 523,899,964.25 | 573,123,555.67 |
| 归属于母公司股东权益合计 | 886,340,513.82 | 882,040,944.59 | 1,533,899,873.57 | 1,581,631,978.74 |
| 少数股东权益 | 49,676,049.68 | 13,925,322.41 | 163,364,886.82 | 160,085,193.24 |
| 股东权益合计 | 936,016,563.5 | 895,966,267 | 1,697,264,760.39 | 1,741,717,171.98 |
| 负债和股东权益合计 | 1,248,911,649.07 | 1,125,109,601.59 | 1,803,223,429.57 | 1,843,315,790.01 |
| 公告日期 | 2026-04-30 | 2026-04-30 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |